Showing results (161-170 of 281) with videos related to
Sort By:
Pageof 29
Circulation|January 19, 2005
Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonismKarine M Egan, Miao Wang, Susanne Fries, et al.American Journal of Respiratory Cell and Molecular Biology|October 22, 2005
Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblastsFerhana Y Ali, Karine Egan, Garret A FitzGerald, et al.Bioorganic & Medicinal Chemistry Letters|September 23, 2008
Eicosapentaenoic-acid-derived isoprostanes: synthesis and discovery of two major isoprostanesChih-Tsung Chang, Pranav Patel, Namin Kang, et al.Journal of Leukocyte Biology|December 1, 2006
Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cellsWeisong Zhou, Timothy S Blackwell, Kasia Goleniewska, et al.Bioorganic & Medicinal Chemistry Letters|October 23, 2009
A new approach to the synthesis of polyunsaturated deuterated isoprostanes: total synthesis of d4-5-epi-8,12-iso-iPF3alpha-VI and d4-8,12-iso-iPF3alpha-VIChih-Tsung Chang, Pranav Patel, Vivek Gore, et al.Journal of Lipid Research|November 29, 2017
Flipping the cyclooxygenase (Ptgs) genes reveals isoform-specific compensatory functionsXinzhi Li, Liudmila L Mazaleuskaya, Chong Yuan, et al.Circulation Research|April 19, 2003
COX-2-dependent cardiac failure in Gh/tTG transgenic miceZhibing Zhang, Roberta Vezza, Theodore Plappert, et al.Proceedings of the National Academy of Sciences of the United States of America|April 12, 2012
Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in miceZhou Yu, Irene Crichton, Soon Yew Tang, et al.Circulation|July 22, 2016
Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1-Deficient Hyperlipidemic MiceSoon Yew Tang, James Monslow, Gregory R Grant, et al.Gastroenterology|January 13, 2006
Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2Susanne Fries, Tilo Grosser, Thomas S Price, et al.Pageof 29